Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17535296rdf:typepubmed:Citationlld:pubmed
pubmed-article:17535296lifeskim:mentionsumls-concept:C0012655lld:lifeskim
pubmed-article:17535296lifeskim:mentionsumls-concept:C0079427lld:lifeskim
pubmed-article:17535296lifeskim:mentionsumls-concept:C0235974lld:lifeskim
pubmed-article:17535296lifeskim:mentionsumls-concept:C0872097lld:lifeskim
pubmed-article:17535296lifeskim:mentionsumls-concept:C1518174lld:lifeskim
pubmed-article:17535296lifeskim:mentionsumls-concept:C0252527lld:lifeskim
pubmed-article:17535296lifeskim:mentionsumls-concept:C0442805lld:lifeskim
pubmed-article:17535296lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:17535296lifeskim:mentionsumls-concept:C1325410lld:lifeskim
pubmed-article:17535296lifeskim:mentionsumls-concept:C1512223lld:lifeskim
pubmed-article:17535296lifeskim:mentionsumls-concept:C1979963lld:lifeskim
pubmed-article:17535296lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:17535296lifeskim:mentionsumls-concept:C2003903lld:lifeskim
pubmed-article:17535296lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:17535296lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:17535296pubmed:issue13lld:pubmed
pubmed-article:17535296pubmed:dateCreated2007-7-5lld:pubmed
pubmed-article:17535296pubmed:abstractTextExpression of the tumor suppressor p16(INK4a) after stable transfection can restore the susceptibility of epithelial tumor cells to anoikis. This property is linked to increases in the expression and cell-surface presence of the fibronectin receptor. Considering its glycan chains as pivotal signals, we assumed an effect of p16(INK4a) on glycosylation. To test this hypothesis for human Capan-1 pancreatic carcinoma cells, we combined microarray for selected glycosyltransferase genes with 2D chromatographic glycan profiling and plant lectin binding. Major differences between p16-positive and control cells were detected. They concerned expression of beta1,4-galactosyltransferases (down-regulation of beta1,4-galactosyltransferases-I/V and up-regulation of beta1,4-galactosyltransferase-IV) as well as decreased alpha2,3-sialylation of O-glycans and alpha2,6-sialylation of N-glycans. The changes are compatible with increased beta(1)-integrin maturation, subunit assembly and binding activity of the alpha(5)beta(1)-integrin. Of further functional relevance in line with our hypothesis, we revealed differential reactivity towards endogenous lectins, especially galectin-1. As a result of reduced sialylation, the cells' capacity to bind galectin-1 was enhanced. In parallel, the level of transcription of the galectin-1 gene increased conspicuously in p16(INK4a)-positive cells, and even figured prominently in a microarray on 1996 tumor-associated genes and in proteomic analysis. The cells therefore gain optimal responsiveness. The correlation between genetically modulated galectin-1 levels and anoikis rates in engineered transfectants inferred functional significance. To connect these findings to the fibronectin receptor, galectin-1 was shown to be co-immunoprecipitated. We conclude that p16(INK4a) orchestrates distinct aspects of glycosylation that are relevant for integrin maturation and reactivity to an endogenous effector as well as the effector's expression. This mechanism establishes a new aspect of p16(INK4a) functionality.lld:pubmed
pubmed-article:17535296pubmed:languageenglld:pubmed
pubmed-article:17535296pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17535296pubmed:citationSubsetIMlld:pubmed
pubmed-article:17535296pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17535296pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17535296pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17535296pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17535296pubmed:statusMEDLINElld:pubmed
pubmed-article:17535296pubmed:monthJullld:pubmed
pubmed-article:17535296pubmed:issn1742-464Xlld:pubmed
pubmed-article:17535296pubmed:authorpubmed-author:NakagawaHiroa...lld:pubmed
pubmed-article:17535296pubmed:authorpubmed-author:NishimuraShin...lld:pubmed
pubmed-article:17535296pubmed:authorpubmed-author:AndréSabineSlld:pubmed
pubmed-article:17535296pubmed:authorpubmed-author:GabiusHans-Jo...lld:pubmed
pubmed-article:17535296pubmed:authorpubmed-author:WiedenmannBer...lld:pubmed
pubmed-article:17535296pubmed:authorpubmed-author:RosewiczStefa...lld:pubmed
pubmed-article:17535296pubmed:authorpubmed-author:von Knebel...lld:pubmed
pubmed-article:17535296pubmed:authorpubmed-author:KopitzJürgenJlld:pubmed
pubmed-article:17535296pubmed:authorpubmed-author:KemmnerWolfga...lld:pubmed
pubmed-article:17535296pubmed:authorpubmed-author:DeguchiKisabu...lld:pubmed
pubmed-article:17535296pubmed:authorpubmed-author:GressThomas...lld:pubmed
pubmed-article:17535296pubmed:authorpubmed-author:BöckCorinaClld:pubmed
pubmed-article:17535296pubmed:authorpubmed-author:BuchholzMalte...lld:pubmed
pubmed-article:17535296pubmed:authorpubmed-author:Sanchez-Ruder...lld:pubmed
pubmed-article:17535296pubmed:authorpubmed-author:ForberichPiaPlld:pubmed
pubmed-article:17535296pubmed:authorpubmed-author:DetjenKathari...lld:pubmed
pubmed-article:17535296pubmed:issnTypePrintlld:pubmed
pubmed-article:17535296pubmed:volume274lld:pubmed
pubmed-article:17535296pubmed:ownerNLMlld:pubmed
pubmed-article:17535296pubmed:authorsCompleteYlld:pubmed
pubmed-article:17535296pubmed:pagination3233-56lld:pubmed
pubmed-article:17535296pubmed:meshHeadingpubmed-meshheading:17535296...lld:pubmed
pubmed-article:17535296pubmed:meshHeadingpubmed-meshheading:17535296...lld:pubmed
pubmed-article:17535296pubmed:meshHeadingpubmed-meshheading:17535296...lld:pubmed
pubmed-article:17535296pubmed:meshHeadingpubmed-meshheading:17535296...lld:pubmed
pubmed-article:17535296pubmed:meshHeadingpubmed-meshheading:17535296...lld:pubmed
pubmed-article:17535296pubmed:meshHeadingpubmed-meshheading:17535296...lld:pubmed
pubmed-article:17535296pubmed:meshHeadingpubmed-meshheading:17535296...lld:pubmed
pubmed-article:17535296pubmed:meshHeadingpubmed-meshheading:17535296...lld:pubmed
pubmed-article:17535296pubmed:meshHeadingpubmed-meshheading:17535296...lld:pubmed
pubmed-article:17535296pubmed:meshHeadingpubmed-meshheading:17535296...lld:pubmed
pubmed-article:17535296pubmed:meshHeadingpubmed-meshheading:17535296...lld:pubmed
pubmed-article:17535296pubmed:meshHeadingpubmed-meshheading:17535296...lld:pubmed
pubmed-article:17535296pubmed:meshHeadingpubmed-meshheading:17535296...lld:pubmed
pubmed-article:17535296pubmed:meshHeadingpubmed-meshheading:17535296...lld:pubmed
pubmed-article:17535296pubmed:meshHeadingpubmed-meshheading:17535296...lld:pubmed
pubmed-article:17535296pubmed:year2007lld:pubmed
pubmed-article:17535296pubmed:articleTitleTumor suppressor p16INK4a--modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells.lld:pubmed
pubmed-article:17535296pubmed:affiliationInstitute of Physiological Chemistry, Faculty of Veterinary Medicine, Ludwig-Maximilians-University Munich, Germany. Sabine.Andre@lmu.delld:pubmed
pubmed-article:17535296pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17535296pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:3956entrezgene:pubmedpubmed-article:17535296lld:entrezgene
entrez-gene:1029entrezgene:pubmedpubmed-article:17535296lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17535296lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17535296lld:entrezgene
lhgdn:association:4763lhgdn:found_inpubmed-article:17535296lld:lhgdn
lhgdn:association:43146lhgdn:found_inpubmed-article:17535296lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17535296lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17535296lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17535296lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17535296lld:pubmed